A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...
Lung and skin cancer patients who were taking "checkpoint inhibitors" and had the COVID vaccine saw surprising results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback